|Alternate Names||SPG64,NTPDase1,ATPDase,CD 39|
1. Aversa GG, et al. 1988. Transplant. P. 20:4952.
2. Aversa GG, et al. 1989. Transplant. P. 21:34950.
3. Borsellino G, et al. 2007. Blood. 110:1225. (Block)
4. Stockl J, et al. 2001. J. Immunol. 167:2724. (IF)
5. Sestak K, et al. 2007. Vet. Immunol. Immunopathol. 119:21.
6. Lyck L, et al. 2008. J. Histochem. Cytochem. 56:201. (IHC)
|Clone No.||A1(See Other Available Formats)|
|Isotype||Mouse IgG1, κ|
|Isotype Control||FITC Mouse IgG1, κ Isotype Control[MOPC-21] [Product E-AB-F09792C]|
|Application||FCM (See the Application Description)|
|Storage Buffer||PBS with 0.05% Proclin300, 1% BSA|
|Recommended Use||Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. The amount of the reagent is suggested to be used 5 μL of antibody per test (million cells in 100 μL staining volume or per 100 μL of whole blood). Please check your vial before the experiment. Since applications vary, the appropriate dilutions must be determined for individual use.|
|Shipping||Biological ice pack at 4℃|
|Stability & Storage||Keep as concentrated solution.
Store at 2~8℃ and protected from prolonged exposure to light. Do not freeze.
Centrifuge before opening to ensure complete recovery of vial contents.
This product is guaranteed up to one year from purchase.
|Human CD39 is an integral membrane protein with two transmembrane domains. It exists as a homotetramer. Expression of CD39 is found on activated lymphocytes, a subset of T cells and B cells, and dendritic cells with weak staining on monocytes and granulocytes. CD39 and CD73 have been found on regulatory T cells, specifically the effector/memory like T cells. CD39 can hydrolyze both nucleoside triphosphates and diphosphates. CD39 is the dominant ecto nucleotidase of vascular and placental trophoblastic tissues and appears to modulate the functional expression of type 2 purinergic (P2) G protein coupled receptors (GPCRs). CD39 has intrinsic ecto-ATPase activity. Expression of CD39 is induced on T cells and increased on B cells as a late activation antigen. Product Details|
|Related Protocols||Staining Cell Surface Targets for Flow Cytometry|
|E-AB-F1165C||FITC Anti-Human CD39 Antibody[A1] E-AB-F1165C||20 Tests, 50 Tests, 100 Tests, 200 Tests|
|E-AB-F1165D||PE Anti-Human CD39 Antibody[A1] E-AB-F1165D||20 Tests, 50 Tests, 100 Tests, 200 Tests|
|E-AB-F1165E||APC Anti-Human CD39 Antibody[A1] E-AB-F1165E||20 Tests, 50 Tests, 100 Tests, 200 Tests|
|E-AB-F1165G||PE/Cyanine5 Anti-Human CD39 Antibody[A1] E-AB-F1165G||20 Tests, 50 Tests, 100 Tests, 200 Tests|
|E-AB-F1165H||PE/Cyanine7 Anti-Human CD39 Antibody[A1] E-AB-F1165H||20 Tests, 50 Tests, 100 Tests, 200 Tests|
|E-AB-F1165I||PE/Cyanine5.5 Anti-Human CD39 Antibody[A1] E-AB-F1165I||20 Tests, 50 Tests, 100 Tests, 200 Tests|
|E-AB-F1165J||PerCP/Cyanine5.5 Anti-Human CD39 Antibody[A1] E-AB-F1165J||20 Tests, 50 Tests, 100 Tests, 200 Tests|
|E-AB-F1165L||AF488 Anti-Human CD39 Antibody[A1] E-AB-F1165L||20 Tests, 50 Tests, 100 Tests, 200 Tests|
|E-AB-F1165M||AF647 Anti-Human CD39 Antibody[A1] E-AB-F1165M||20 Tests, 50 Tests, 100 Tests, 200 Tests|